ID   GM03891
AC   CVCL_W305
SY   GM 3891
DR   CLO; CLO_0016008
DR   BioSample; SAMN00808596
DR   Coriell; GM03891
DR   Wikidata; Q54838304
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W306 ! GM03892
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   PubMed=6726265; DOI=10.1136/jnnp.47.4.391;
RA   Robbins J.H., Scudiero D.A., Otsuka F., Tarone R.E., Brumback R.A.,
RA   Wirtschafter J.D., Polinsky R.J., Barrett S.F., Moshell A.N.,
RA   Scarpinato R.G., Ganges M.B., Nee L.E., Meyer S.A., Clatterbuck B.E.;
RT   "Hypersensitivity to DNA-damaging agents in cultured cells from
RT   patients with Usher's syndrome and Duchenne muscular dystrophy.";
RL   J. Neurol. Neurosurg. Psych. 47:391-398(1984).
//